236 related articles for article (PubMed ID: 34575885)
41. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
42. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
[TBL] [Abstract][Full Text] [Related]
43. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
Brunden KR; Zhang B; Carroll J; Yao Y; Potuzak JS; Hogan AM; Iba M; James MJ; Xie SX; Ballatore C; Smith AB; Lee VM; Trojanowski JQ
J Neurosci; 2010 Oct; 30(41):13861-6. PubMed ID: 20943926
[TBL] [Abstract][Full Text] [Related]
44. Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy.
Wobst HJ; Denk F; Oliver PL; Livieratos A; Taylor TN; Knudsen MH; Bengoa-Vergniory N; Bannerman D; Wade-Martins R
Sci Rep; 2017 Feb; 7():43198. PubMed ID: 28233851
[TBL] [Abstract][Full Text] [Related]
45. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.
Schaeffer V; Lavenir I; Ozcelik S; Tolnay M; Winkler DT; Goedert M
Brain; 2012 Jul; 135(Pt 7):2169-77. PubMed ID: 22689910
[TBL] [Abstract][Full Text] [Related]
46. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
47. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
[TBL] [Abstract][Full Text] [Related]
48. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
Carroll JC; Iba M; Bangasser DA; Valentino RJ; James MJ; Brunden KR; Lee VM; Trojanowski JQ
J Neurosci; 2011 Oct; 31(40):14436-49. PubMed ID: 21976528
[TBL] [Abstract][Full Text] [Related]
49. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
[TBL] [Abstract][Full Text] [Related]
50. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
[TBL] [Abstract][Full Text] [Related]
51. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
[TBL] [Abstract][Full Text] [Related]
52. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy.
Merchán-Rubira J; Sebastián-Serrano Á; Díaz-Hernández M; Avila J; Hernández F
Neurosci Lett; 2019 Apr; 698():204-208. PubMed ID: 30677432
[TBL] [Abstract][Full Text] [Related]
53. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau.
Schweighauser M; Murzin AG; Macdonald J; Lavenir I; Crowther RA; Scheres SHW; Goedert M
Acta Neuropathol Commun; 2023 Oct; 11(1):160. PubMed ID: 37798679
[TBL] [Abstract][Full Text] [Related]
54. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.
Sankaranarayanan S; Barten DM; Vana L; Devidze N; Yang L; Cadelina G; Hoque N; DeCarr L; Keenan S; Lin A; Cao Y; Snyder B; Zhang B; Nitla M; Hirschfeld G; Barrezueta N; Polson C; Wes P; Rangan VS; Cacace A; Albright CF; Meredith J; Trojanowski JQ; Lee VM; Brunden KR; Ahlijanian M
PLoS One; 2015; 10(5):e0125614. PubMed ID: 25933020
[TBL] [Abstract][Full Text] [Related]
55. Tau silencing by siRNA in the P301S mouse model of tauopathy.
Xu H; Rösler TW; Carlsson T; de Andrade A; Fiala O; Hollerhage M; Oertel WH; Goedert M; Aigner A; Höglinger GU
Curr Gene Ther; 2014; 14(5):343-51. PubMed ID: 25687501
[TBL] [Abstract][Full Text] [Related]
56. Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics.
Woo JA; Liu T; Fang CC; Cazzaro S; Kee T; LePochat P; Yrigoin K; Penn C; Zhao X; Wang X; Liggett SB; Kang DE
Commun Biol; 2019; 2():112. PubMed ID: 30911686
[TBL] [Abstract][Full Text] [Related]
57. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E
PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611
[TBL] [Abstract][Full Text] [Related]
58. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
[TBL] [Abstract][Full Text] [Related]
59. 3R tau expression modifies behavior in transgenic mice.
Shiryaev N; Jouroukhin Y; Gozes I
J Neurosci Res; 2010 Sep; 88(12):2727-35. PubMed ID: 20544828
[TBL] [Abstract][Full Text] [Related]
60. Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP
Briggs DI; Defensor E; Memar Ardestani P; Yi B; Halpain M; Seabrook G; Shamloo M
eNeuro; 2017; 4(4):. PubMed ID: 28721361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
